Xarelto Manufacturers Continue to Pursue FDA Approval Even as Lawsuits Rise

It was recently announced that Bayer and Johnson & Johnson, the manufacturers of Xarelto, will continue to pursue additional FDA approvals for the drug, only this time, for stroke patients. Even as the two manufacturers continue to be hit with lawsuits by consumers who have been injured by the drug, they continue to pursue permission to market the drug for off-label use.

Considering that there are currently hundreds of lawsuits being filed against Xarelto, it would seem like an rash decision by Bayer and Johnson & Johnson to continue to pursue FDA approvals. In December and January, the lawsuits that have been filed against the two manufacturers were consolidated into multidistrict litigation in two U.S. courts, as well as into a mass tort program.

As the lawsuits regarding Xarelto continue to rise, it’s important that consumers be aware of the potential deadly side effects that consumption of the pharmaceutical drug can have. In many cases, patients have been prescribed the blood thinner after knee or hip surgery. Unfortunately, because Xarelto does not yet have an antidote, patients may experience internal bleeding. Thousands of people have thus far been injured by the drug and the number of lawsuits has similarly risen in the past few months.

 

Legal Commentary
Xarelto attorneys within our firm are studying, examining and investigating current Xarelto claims on behalf of people or families injured by the drug. Some of the side effects include hemorrhaging, internal bleeding, stroke and or death. If you or a loved one has experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at 1.866.705.7584 or by email at mn@fnlawfirm.com.


About the Author
Majed Nachawati is a dedicated Xarelto Lawyer with a focus on representing victims and families harmed by this dangerous drug on a nationwide basis. Mr. Nachawati has resolved numerous dangerous drug medication cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past six consecutive years for legal excellence, in connection with noteworthy settlements for pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.
 

45-Year-Old Construction Worker Killed in Crane Accident in Portage, Indiana

Pictured above: Construction workers and firemen at the scene of the accident 

Last Friday, an accident took the life of a worker who was employed on a construction site. The accident happened in the Near North Side neighborhood in Portage, Indiana. Joel Ogiego, the 45-year-old victim, was working on a construction site when, according to officials, he became pinned in a shaft. Mr. Ogiego was working about 60 feet above ground and inside a crane at 4 E. Elm St when a cage descended on him and crushed him.

Mr. Ogiego become unconscious and unresponsive and had to be lowered down before being rushed to Northwestern Hospital. A firefighter on the scene states that the injuries were too traumatic and little could have been done to save the construction worker.

OSHA, the Occupational Safety and Health Administration, is investigating the accident, along with other local authorities. After on-the-job accidents, OSHA is regularly called in to verify whether or not an accident could have been prevented. In this case, authorities are stating that the crane operations involved in the accident could have contributed to the fatality. If OSHA finds that Mr. Ogiego’s employers did not adequately provide safe working conditions, OSHA can issue citations and monetary penalties to the company. Mr. Ogiego’s family may also be able to pursue a civil claim against the employer in question.

 

Legal Commentary
In this situation and the accidents before it, the most pertinent legal matter to pursue is a civil case. From a civil standpoint, our firm has represented numerous families who are the victims of workplace accident tragedies. A successful civil claim will enable their families to receive rightful financial compensation. If you or a loved one was affected by this incident, or one similar, contact the experienced attorneys at Fears | Nachawati Law Firm by sending an email to mn@fnlawfirm.com or by calling our office at 1.866.705.7584.

About the Author
Majed Nachawati is a preeminent personal injury lawyer with a focus on representing victims and families involved in workplace accidents, automobile accidents, wrongful death cases, and product liability claims throughout the state of Texas. Mr. Nachawati has resolved numerous workplace motor vehicle accident cases through trial and settlement that have brought seven and eight figure confidential reward settlements. His is on the Grievance Committee for the State Bar of Texas. He is licensed to practice before the Supreme Court of Texas and Arkansas and is licensed in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leader’s Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past five years in a row for legal excellence, in connection with wrongful death and products liability cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be contacted by email or by calling 1.866.705.7584.

4-Year-Old Killed by Waste And Recycling Truck in Albany, NY

Pictured above: the waste and recycling truck that hit and killed a young boy in Albany, NY 

Two weeks ago, in Albany, NY, a 4-year-old boy was hit and killed by a waste and recycling truck. The young boy was hit while crossing the intersection of Central Avenue and Quail Street. He was transported to a nearby hospital immediately after the accident but later died from his injuries.

ICS Waste and Recycling, the trucking company that owns the truck in this accident, claims that the young boy jumped a snow back and into the road without warning. Police and authorities, however, dispute this, stating that video evidence shows the young boy and his mother were holding hands and crossing the sidewalk and had the right of way. Police also state that the truck had a green light but that the woman and her son also had the green light to cross the street.

Although no one has been charged or cited, police state their investigation is still ongoing. A crossing guard who was at the scene claims that this particular intersection has some of the worst traffic and that pedestrians have to be even more cautious when crossing the street.

Legal Commentary
Unfortunately, truck accidents are quite common. From a civil standpoint, our firm has represented numerous victims and their families who are affected by a motor vehicle accident. A successful civil claim would enable the survivors and their families to cover any needed medical expenses. A successful claim can also possibly cover any time lost from work or any pain and suffering caused by the injuries received from the accident. If you or a loved one was affected by a trucking accident, contact the experienced attorneys at Fears | Nachawati Law Firm by sending an email to mn@fnlawfirm.com or by calling our office at 1.866.705.7584.

About the Author
Majed Nachawati is a preeminent personal injury lawyer with a focus on representing victims and families involved in automobile accidents, wrongful death cases, and product liability claims throughout the state of Texas. Mr. Nachawati has resolved numerous workplace motor vehicle accident cases through trial and settlement that have brought seven and eight figure confidential reward settlements. His is on the Grievance Committee for the State Bar of Texas. He is licensed to practice before the Supreme Court of Texas and Arkansas and is licensed in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leader’s Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past five years in a row for legal excellence, in connection with wrongful death and products liability cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be contacted by email or by calling 1.866.705.7584.

 

Fatigued Walmart 18-Wheeler Driver Hits Vehicle Head-On in Fatal Accident

video platformvideo managementvideo solutionsvideo player

A recent trucking accident in Jacksonville, Florida has brought Wal-Mart into the spotlight again, after one of their semi-truck drivers hit and killed a man. The accident occurred last June, in 2014, when Wiley Clark was driving near his home when the truck driver, Wilbur Peterson, crossed a media and hit Clark’s car head-on. Attorneys and Clark’s widow, Bonnie Clark, assert that the driver of the 18-wheeler was fatigued and driving a truck with several maintenance issues. The driver was working for Swift Transportation, a company that works with Walmart.

They also maintain that the company had willingly allowed Peterson to drive more hours than allowed. A week before the accident, he had driven 65 hours and at the time of the accident, was asked to drive a 12-hour shift. He was also driving 17 miles over the speed limit and the tires on his rig were worn down to 1/32nd of a inch, further violating federal standards. Unfortunately, in their attempt to get as much work out of a driver as possible, both Swift Transportation and Walmart needlessly put other people’s lives in danger and contributed to the death of Mr. Clark. Attorneys for Bonnie Clark state they are seeking compensation from Swift Transportation, Walmart and their driver.

Legal Commentary
Unfortunately, truck accidents are quite common. In this situation, Mr. Clark's widow has chosen to pursue a civil claim as a result of negligence on the part of Swift Transportation, Walmart, and their driver. From a civil standpoint, our firm has represented numerous victims and their families who are affected by a motor vehicle accident. A successful civil claim would enable the survivors and their families to cover any needed medical expenses. A successful claim can also possibly cover any time lost from work or any pain and suffering caused by the injuries received from the accident. If you or a loved one was affected by a trucking accident, contact the experienced attorneys at Fears | Nachawati Law Firm by sending an email to mn@fnlawfirm.com or by calling our office at 1.866.705.7584.


About the Author
Majed Nachawati is a preeminent personal injury lawyer with a focus on representing victims and families involved in automobile accidents, wrongful death cases, and product liability claims throughout the state of Texas. Mr. Nachawati has resolved numerous workplace motor vehicle accident cases through trial and settlement that have brought seven and eight figure confidential reward settlements. His is on the Grievance Committee for the State Bar of Texas. He is licensed to practice before the Supreme Court of Texas and Arkansas and is licensed in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leader’s Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past five years in a row for legal excellence, in connection with wrongful death and products liability cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be contacted by email or by calling 1.866.705.7584.

 

Dentist Charged With Negligent Homicide After Patient Dies During Procedure

Pictured above: Rashmi Patel, the Connecticut dentist being charged 

Last Thursday, on February 19, a Connecticut dentist was charged in the death of a patient he was treating. Rashmi Patel was extracting 20 teeth and implanting several implants on a patient when they became unresponsive. According to police, Patel is being charged with criminally negligent homicide and tampering with evidence.

Unfortunately, this is not the first time a patient has died at the hands of this dentist. A year ago, Judith Gan, another patient under going a similar tooth extraction and implant procedure, died under Patel’s care. According to state dental regulators, Patel did not adequately respond to Gan when she was in distress. He also ignored warnings from his dental assistants. A Dental Commission hearing also claimed that Patel should not have tried to perform so many procedures on Gan at one time, especially given that she had had a heart attack within six months of the dental procedure.

In one other instance in 2013, Patel failed to protect a patient after he swallowed a piece of gauze while under continued sedation. Fortunately, the patient survived after being rushed to a hospital.

 

Legal Commentary
A seemingly routine dental procedure should not end in death if a dentist is taking the proper precautions and care. Medical providers have a duty to provide exceptional care given that their patients are placing their health and lives in the hands of professionals. When medical malpractice occurs, it may be difficult to determine where exactly a provider failed to provide adequate care but with the proper legal counsel, you may have a civil case worth persuing. Fears | Nachawati attorneys routinely handle life-changing medical malpractice cases on a nationwide basis and have obtained unparalleled results for its clients.
If you or a loved one has been harmed by the care of a medical professional, then you need the services of an experienced medical malpractice attorney with the resources to take the case to trial. We encourage you to call us or contact us online today to receive a free confidential consultation.

About the Author
Majed Nachawati is a preeminent personal injury lawyer with a focus on representing victims and families involved in automobile accidents, workplace accidents, wrongful death cases, and product liability claims throughout the state of Texas. Mr. Nachawati has resolved numerous workplace motor vehicle accident cases through trial and settlement that have brought seven and eight figure confidential reward settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice before the Supreme Court of Texas and Arkansas and is licensed in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leader’s Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past five years in a row for legal excellence, in connection with wrongful death and products liability cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be contacted by mn@fnlawfirm.com or by calling 1.866.705.7584.

 

 

JAMA Study Reveals Clinical Trial Misconduct for Xarelto

On February 9th, 2015, JAMA Internal Medicine published an article stating that although the U.S. Food and Drug Administration (FDA) frequently finds problems with the way in which clinical sites perform biomedical research on human participants, this information is hardly ever distributed properly or adequately addressed when trials are published. Scientists who run these trials may be failing to adhere to good clinical practices and the proper research conduct. These violations may include any of the following: a failure to adhere to clinical trial protocols, inadequate or inaccurate record keeping, falsification of reports, or a failure in ensuring the safety of a patient.

Unfortunately, because the FDA has no adequate system in place to communicate these findings to others in the scientific community, other scientists are not properly notified, let alone the general public. Even more astounding is the fact that, out of all these questionable situations, only 4% of these unacceptable conditions and practices are ever revealed. In other words, 3 out of 78 publications actually make clear that within their study, violations were found and what those violations are. For patients, this means that not only are they being treated by a potentially dangerous drug, they may also have no accurate and factual information available to them.

One such case is in regards to the drug Xarelto (generic: rivaroxaban), a blood thinner that has been recently introduced into the pharmaceutical market. Charles Seife, the researcher heading the JAMA study, found that the FDA conducted 16 inspections of the drug and found 8 undisclosed instances of wrongdoing. During these trials, scientists - among other things - falsified data, discarded medical records, and knowingly revealed which patients were receiving the actual drug or a placebo. Although FDA considered the studies unreliable, they were still published, minus the above violations listed.

Unfortunately, even though this new study shows clear problems with the way in which the Xarelto clinical trials were conducted, the drug is still on the market and still harming consumers. The drug, developed and distributed by Johnson & Johnson’s Janssen Pharmaceuticals and Bayer Healthcare, has recently come under fire because of its potentially deadly side effects. The drug is prescribed to patients as an anticoagulant but has no reversal agent. This means that patients are at an increased risk of developing unstoppable internal bleeding that may result in death. If the JAMA study is any indication, it is no surprise that this drug has caused a number of problems for doctors and patients and as such, should not be on the market.


Legal Commentary

Many patients and their attorneys argue that the manufacturers of Xarelto, which include Bayer, Janssen Pharmaceutical and Johnson & Johnson, have withheld information and have not properly warned the public about the risks of this dangerous drug. The above JAMA study only serves to show that the manufacturers of Xarelto have acted negligently in producing this drug. If you or a loved one has fallen victim to any of the side effects of Xarelto, then seeking legal advice may provide you with the ability to hold the manufacturers accountable. Our attorneys have years of experience battling big pharmaceutical corporations. If you would like free legal information about your Xarelto case, call us for a free case evaluation. You can reach us at 1.866.705.7584 or by email at mn@fnlawfirm.com.


About the Author
Majed Nachawati is a preeminent Xarelto Lawyer with a focus on representing Xarelto victims and families harmed by this dangerous drug on a nationwide basis. Mr. Nachawati has resolved numerous cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past six consecutive years for legal excellence, in connection with pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email
 

Snowplow Hits and Kills Bicyclist in North Carolina

Pictured above: The snowplow involved in the deadly accident 

This winter has been especially harsh for the Northeast this year, which for most cities means bringing out more snowplows and personnel. Unfortunately, it can also mean more accidents. Yesterday morning, Fedora M. Henderson, a 31-year-old woman biking to work, was struck by a VDOT snowplow in Glen Allen, Virginia. The VDOT plow driver was clearing snow on the northbound lane on Route 1 when the vehicle collided with Henderson. Bradley W. Stenroos, the driver of the snowplow, was uninjured.  

Friends of Henderson say she always rode her bike to work, as it was her only means of transportation. A VDOT spokesperson states that Stenroos was driving safely when the accident occurred but police are still conducting an investigation. 

Legal Commentary 

As temperatures continue to decrease and road conditions worsen, it can also unfortunately mean an increase in accidents. It’s important that city personnel and pedestrians alike remain vigilant of their surroundings, especially on icy roads and after heavy snowfall. We urge drivers and bicyclists to take it slow when weather conditions are dangerous and to remain alert and aware of snowplows and other large vehicles while on the road. If you've been injured in these icy conditions due to another driver, you may be able to pursue a legal claim for any physical injuries the accident cuased you. A successful claim can also possibly cover any time lost from work or any pain and suffering caused by the injuries received from the accident. If you or a loved one was affected by this incident or one similar, contact the experienced attorneys at Fears | Nachawati Law Firm by sending an email to mn@fnlawfirm.com or by calling our office at 1.866.705.7584.

About the Author
Majed Nachawati is a preeminent personal injury lawyer with a focus on representing victims and families involved in automobile accidents, wrongful death cases, and product liability claims throughout the state of Texas. Mr. Nachawati has resolved numerous workplace motor vehicle accident cases through trial and settlement that have brought seven and eight figure confidential reward settlements. His is on the Grievance Committee for the State Bar of Texas. He is licensed to practice before the Supreme Court of Texas and Arkansas and is licensed in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leader’s Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past five years in a row for legal excellence, in connection with wrongful death and products liability cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be contacted by email or by calling 1.866.705.7584.

Xarelto and FDA Approval

Xarelto is an anticoagulant drug approved by the Food and Drug Administration (“FDA”) for three primary uses—to treat patients who are at risk of developing blood clots after knee or hip replacement surgery, to treat those who are at risk of strokes, pulmonary embolism, and deep vein thrombosis and those who are experiencing atrial fibrillation. The Food and Drug Administration did not approve Xarelto to treat all three health conditions at once. The FDA approved Xarelto as treatment for each concern after some research and time.

In July of 2011, the FDA approved Xarelto as a way to reduce the risk of blood clots that may happen after knee or hip replacement surgery. The news release stated that Xarelto should be taken once a day for 12 or 35 days, depending on the type of surgery that was preformed. In November of 2011, the FDA allowed Xarelto to be prescribed to patients who have an abnormal heart beat, also known as atrial fibrillation. Atrial fibrillation occurs when the beatings of the two upper heart chambers are irregular; this leads to blood pooling in the heart’s upper chambers. The pools of blood, or blood clots, travel to the brain and block the blood flow which leads to a stroke. Xarelto can prevent the blood clots, which ultimately prevents the risk of a stroke from occurring. Therefore, the risk of a stroke is reduced in patients taking Xarelto who have atrial fibrillation. In November of 2012, the FDA approved the use of Xarelto to treat deep vein thrombosis and pulmonary embolism. Deep vein thrombosis, also known as DVT, occurs when a blood clot forms in a vein deep within the body. The blood clot has the possibility to break off and travel to an artery in the lungs, blocking the flow of blood. This deadly process is called pulmonary embolism, also known as PE.

To date, thousands of Xarelto lawsuits are filed against the manufacturers and distributors of Xarelto which consist of Bayer, Janssen Pharmaceuticals and Johnson & Johnson, for misleading the public about this dangerous anticoagulant drug. One of the main side effects of Xarelto is severe internal bleeding. There is no effective way to stop the bleeding, which can result in death. The lawsuit alleges that the Xarelto manufactures knew of the potential side effects and knew that there was no treatment, reversal agent or antidote to stop the bleeding.

Legal Commentary

Xarelto attorneys within our firm are studying, examining and investigating current Xarelto claims on behalf of people or families injured by Xarelto. Some of the side effects include hemorrhaging, internal bleeding, stroke and or death. If you or a loved one has experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a Free consultation at 1.866.705.7584 or by email at mn@fnlawfirm.com.

About the Author

Majed Nachawati is a preeminent Xarelto Lawyer with a focus on representing victims and families harmed by this dangerous drug on a nationwide basis. Mr. Nachawati has resolved numerous dangerous drug medication cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past six consecutive years for legal excellence, in connection with noteworthy settlements for pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

Xarelto Health Risks

Xarelto is one of the newest blood thinners on the market. The anticoagulant drug is prescribed to patients who have experienced atrial fibulation, are at risk of developing severe blood clots after hip or knee replacement surgery and or to reduce the risk of strokes, pulmonary embolism and deep vein thrombosis. Xarelto is popular because it does not require patients to undergo blood tests to determine the dose and it does not require patients to go in for a routine check-up with their physician. Recently, the health hazards related to Xarelto are alarming; the drug can be fatal by causing abdominal bleeding, hemorrhaging and bleeding in the brain. While most blood thinners on the market have a cure to stop internal bleeding, Xarelto does not. Currently, there is no antidote to stop or reverse the bleeding caused by Xarelto.  Xarelto is designed to stop blood from clotting. There are 13 specific proteins in the blood will start the clotting process. Xarelto is intended to block the protein which prevents the blood clots from forming. This process can be very dangerous if an injury occurs, especially in older adults, because of the possibility of uncontrolled bleeding. Many patients who suffer from severe internal bleeding end up in the hospital, but doctors have no way to reverse the bleeding, which sometimes tragically results in death.

Legal Commentary

Many patients and their attorneys argue that the manufacturers of Xarelto, which include Bayer, Janssen Pharmaceutical and Johnson & Johnson, withheld information and did not properly warn the public about the risks of this dangerous drug. If you or a loved one has fallen victim to any of the side effects of Xarelto, then seeking legal advice may provide you with the ability to hold the manufacturers accountable. Our attorneys have years of experience battling big pharmaceutical corporations.  If you would like free legal information about your Xarelto case, call us for a free case evaluation. You can reach us at 1.866.705.7584 or by email at mn@fnlawfirm.com.

About the Author

Majed Nachawati is a preeminent Xarelto Lawyer with a focus on representing Xarelto victims and families harmed by this dangerous drug on a nationwide basis. Mr. Nachawati has resolved numerous cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past six consecutive years for legal excellence, in connection with pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email

Xarelto Injury Law Firms Selected for Leadership Positions by Judge Eldon Fallon

Xarelto attorney leadership positions have been selected for the Xarelto lawsuits previously filed, consolidated, coordinated and assigned to Judge Eldon Fallon.  Out of 100 Xarelto injury lawsuits filed, Judge Fallon selected a group of plaintiffs’ attorneys to serve in a variety of leadership roles. Judge Fallon appointed twelve attorneys to leadership positions who are charged with various pretrial procedures including, but not limited to conducting discovery, speaking on behalf of plaintiffs at hearings and negotiating prospective settlements with defendants, Bayer, Janssen and Johnson & Johnson. The leadership roles were created to minimize duplicative discovery and to serve all parties involved without conflicting rulings from multiple judges.

Xarelto was approved in July of 2011 by the Food & Drug Administration and is one of the newest blood thinners on the market today. This drug belongs to a class of anti-coagulants that is marketed by both Bayer, Janssen and Johnson & Johnson to reduce the risk and formation of blood clots and stroke, treat deep vein thrombosis and pulmonary embolism, and to reduce the risk of blood clots in patients undergoing hip and knee replacement surgery. While the medication was intended to help, its adverse side effects were seemingly far more dangerous. Unfortunately, the serious and fatal side effects of this drug were not known until after patients began using it. One of the most dangerous side effects for people taking Xarelto includes death caused by uncontrollable bleeding. To date, there is no anti-dote for the bleeding nor is there an effective way to stop the bleeding.

The litigation process is not over, while Judge Fallon has about 100 cases, there are expected to be thousands more Xarelto lawsuits filed throughout the U.S. Since Xarelto litigation is rapidly growing, a selected group of claims will go through the discovery, deposition and trial process to see how juries respond to the cases. Judges can gauge the outcome of other potential Xarelto settlements based on the outcome of the group of claims that went before juries in the U.S. District Court.   

Legal Commentary: The Xarelto lawyers at our firm are currently investigating claims for those affected by Xarelto. From a civil standpoint, our firm has represented thousands of individuals and families who have become victims to Xarelto or its side effects. If you or a loved one has experienced bleeding, blood clots, death or other serious complications while taking Xarelto, contact our pharmaceutical lawyers for a free consultation and case evaluation about your potential Xarelto lawsuit. You can reach us at 866.705.7584 or by email at mn@fnlawfirm.com.

About the Author: Majed Nachawati is a preeminent Pharmaceutical Products Liability Lawyer with a focus on representing Xarelto victims and families harmed by dangerous drugs on a nationwide basis. Mr. Nachawati has resolved numerous cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past five consecutive years for legal excellence, in connection with pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.‚Äč